Clinical Trials Logo

POAG clinical trials

View clinical trials related to POAG.

Filter by:
  • None
  • Page 1

NCT ID: NCT05902871 Not yet recruiting - POAG Clinical Trials

Direct Selective Laser Trabeculoplasty in a Ethnic Chinese Population

Zhuiguangzhe
Start date: June 15, 2023
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the safety and effectiveness of Direct Selective Laser Trabeculoplasty (DSLT) at various energy settings in ethnic Chinese participants with POAG or OHT.

NCT ID: NCT05696561 Not yet recruiting - POAG Clinical Trials

Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma

Start date: June 2024
Phase: N/A
Study type: Interventional

Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects with Open-Angle Glaucoma

NCT ID: NCT05278299 Active, not recruiting - POAG Clinical Trials

Asia Glaucoma Registry

Start date: October 1, 2021
Phase:
Study type: Observational

Glaucoma remains a leading cause for irreversible visual impairment and blindness worldwide and it disproportionately affects people residing in Asia, there is a need to ensure optimal management of the disease in patients with glaucoma. The ability to estimate the rates of structural and functional loss in patients with glaucoma will enable clinicians to identify those with rapidly deteriorating conditions or those at-risk, and to therefore provide timely treatment to these patients. Despite this, there are currently several challenges in identifying rapid-progressors in glaucoma, including lack of consensus on the definition of 'rapid' progression and what rates of change of visual field (VF) encompass clinically significant deterioration relevant to the patients. As such, the Asia Glaucoma Registry is intended to collect data to advance the understanding of glaucoma and its progression in Asia and to understand the management patterns of glaucoma in Asia. The Registry will also provide research data for future collaborative scientific research projects.

NCT ID: NCT05062668 Recruiting - POAG Clinical Trials

Efficacy and Safety of iStent Inject and Inject W in the Management of Primary Open-angle Glaucoma

EII
Start date: October 8, 2021
Phase:
Study type: Observational

Primary open-angle glaucoma (POAG) is a chronic eye disease in which the only validated treatment is to lower intraocular pressure (IOP). It is the 2nd leading cause of blindness worldwide. The iStent® inject and inject W is an implantable device that is part of a new entity of so-called minimally invasive glaucoma surgery whose goal is to lower IOP with minimal tissue disruption in order to avoid the complications of conventional glaucoma surgery. This surgery is used in conjunction with cataract surgery in France. The primary objective is to study the 1-year efficacy and safety of combined cataract and iStent inject and inject W in the management of POAG in an observational, retrospective, controlled study of a cohort of POAG patients undergoing cataract surgery only.

NCT ID: NCT02792803 Recruiting - Ocular Hypertension Clinical Trials

A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma

Start date: September 2015
Phase: Phase 4
Study type: Interventional

The purpose of the study is to provide evidence that the efficacy of Xalatan will be superior to Apo-latanoprost and Co-latanoprost in the reduction of intraocular pressure in patients with primary open angle glaucoma. The study will also aim to prove the tolerability of Xalatan in terms of ocular hyperemia will be equivalent to its generic counterparts.

NCT ID: NCT02312362 Recruiting - Cataract Clinical Trials

High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP

HFDS_abinterno
Start date: November 2012
Phase: N/A
Study type: Interventional

Objective: To compare intraocular pressure lowering effect of combined sclerotomy ab interno with phacoemulsification and phacoemulsification alone, in primary or secondary open angle glaucoma patients. Study design: Prospective, randomized, case- control interventional surgical trial